Computational analysis of the number, area and density of γ-H2AX foci in breast cancer cells exposed to 111In-DTPA-hEGF or γ-rays using Image-J software

International Journal of Radiation Biology

Volumn 85, Issue 3, 2009, Pages 262-271

  Cai, Zhongli ^a   Vallis, Katherine A ^b   Reilly, Raymond M ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

H2AX foci; rays; 111In DTPA hEGF; Breast cancer cells; DNA double strand breaks; Image J

Indexed keywords

DIETHYLENETRIAMINEPENTAACETIC ACID IN 111 HUMAN EPIDERMAL GROWTH FACTOR; GAMMA UROGASTRONE; HISTONE H2AX; PENTETATE INDIUM IN 111; PHOSPHOHISTONE H2AX; SERINE; UNCLASSIFIED DRUG; 111IN DTPA HUMAN EPIDERMAL GROWTH FACTOR; 111IN-DTPA-HUMAN EPIDERMAL GROWTH FACTOR; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR; H2AFX PROTEIN, HUMAN; HISTONE; INDIUM; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL NUCLEUS; COMPUTER PROGRAM; DENSITY; DOUBLE STRANDED DNA BREAK; GAMMA RADIATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RADIATION ABSORPTION; RADIATION DOSE; RADIOACTIVITY; BREAST TUMOR; FEMALE; METABOLISM; PHOSPHORYLATION; RADIATION EXPOSURE; RADIATION RESPONSE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; DNA BREAKS, DOUBLE-STRANDED; DOSE-RESPONSE RELATIONSHIP, RADIATION; EPIDERMAL GROWTH FACTOR; FEMALE; GAMMA RAYS; HISTONES; HUMANS; INDIUM RADIOISOTOPES; PENTETIC ACID; PHOSPHORYLATION; RADIOPHARMACEUTICALS; SOFTWARE;

EID: 67449088381     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000902748757     Document Type: Article

References (33)

1. Aten JA, Stap J, Krawczyk PM, van Oven CH, Hoebe RA, Essers J, Kanaar R. 2004. Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains. Science 303:92-95.
2. 111In-DTPA human epidermal growth factor. Journal of Nuclear Medicine 48:1562-1570.
3. Banáth JP, Macphail SH, Olive PL, 2004. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Research 64:7144-7149.
4. Böcker W, Iliakis G. 2006. Computational methods for analysis of foci: Validation for radiation-induced gamma-H2AX foci in human cells. Radiation Research 165:113-124.
5. 111In-DTPA-hEGF. Journal of Nuclear Medicine 49:1353-1361.
6. 111In-DTPA-hEGF, chemotherapeutic agents and γ-radiation on EGFR-positive breast cancer cells. Nuclear Medicine and Biology 29:693-699.
7. 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Journal of Nuclear Medicine 44: 1469-1478.
8. 111Inlabeled Trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): An Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer. Journal of Nuclear Medicine 48:1357-1368.
9. Fester T, Berg RH, Taylor CG. 2008. An easy method using glutaraldehyde-introduced fluorescence for the microscopic analysis of plant biotrophic interactions. Journal of Microscopy 231:342-348.
10. Goddu SM, Howell RW, Rao DV. 1994. Cellular dosimetry: Absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. Journal of Nuclear Medicine 35:303-316.
11. Howell RW. 1992. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 19:1371-1383.
12. 111In]DTPA-hEGF. Nuclear Medicine and Biology 34:887-896.
13. Kato TA, Okayasu R, Bedford JS. 2008. Comparison of the induction and disappearance of DNA double strand breaks and [gamma]-H2AX foci after irradiation of chromosomes in G1phase or in condensed metaphase cells. Mutation Research/ Fundamental and Molecular Mechanisms of Mutagenesis 639:108-112.
14. Kotsopoulos J, Chen Z, Vallis KA, Poll A, Ainsworth P, Narod SA. 2007. DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers. British Journal of Cancer 96:118-125.
15. Leatherbarrow EL, Harper JV, Cucinotta FA, O'Neill P. 2006. Induction and quantification of gamma-H2AX foci following low and high LET-irradiation. International Journal of Radiation Biology 82:111-118.
16. Lin SY, Makino K, Loizidou M, et al. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biology 3:802-808.
17. MacPhail SH, Banáth JP, Yu TY, Chu EHM, Lambur H, Olive PL. 2003. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. International Journal of Radiation Biology 79:351-358.
18. Mahrhofer H, Burger S, Oppitz U, Flentje M, Djuzenova CS. 2006. Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation. International Journal of Radiation Oncology Biology Physics 64:573-580.
19. Pilch DR, Sedelnikova OA, Redon C, Celeste A, Nussenzweig A, Bonner WM. 2003. Characteristics of gamma-H2AX foci at DNA double strand breaks sites. Biochemistry and Cell Biology-Biochimie et Biologie Cellulaire 81:123-129.
20. Qvarnstrom OF, Simonsson M, Johansson KA, Nyman J, Turesson I. 2004. DNA double strand break quantification in skin biopsies. Radiotherapy and Oncology 72:311-317.
21. Rampaul RS, Pinder SE, Nicholson RI, Gullick WJ, Robertson JF, Ellis IO. 2005. Clinical value of epidermal growth factor receptor expression in primary breast cancer. Advances in Anatomic Pathology 12:271-273.
22. Rao VA, Agama K, Holbeck S, Pommier Y. 2007. Batracylin (NSC 320846), a dual inhibitor of DNA Topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage. Cancer Research 67:9971-9979.
23. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpres-sing EGFR. Journal of Nuclear Medicine 41:429-438.
24. 111In for radiotherapeutic applications. Journal of Nuclear Medicine 45:701-708.
25. Reilly RM. 2007. The radiopharmaceutical science of monoclonal antibodies and peptides for imaging and targeted in situ radiotherapy of malignancies. In: Gad SC, editor. Handbook of Pharmaceutical Biotechnology, Hoboken, NJ: John Wiley & Sons. Chapter 6.7pp 883-942.
26. Rothkamm K, Lobrich M. 2003. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proceedings of the National Academy of Sciences of the USA 100:5057-5062.
27. Sak A, Grehl S, Erichsen P, Engelhard M, Grannass A, Levegrun S, Pottgen C, Groneberg M, Stuschke M. 2007. Gamma-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: Dependence on the dose-distribution, irradiated site and time from start of treatment. International Journal of Radiation Biology 83:639-652.
28. Sak A, Stueben G, Groneberg M, Bocker W, Stuschke M. 2005. Targeting of Rad51-dependent homologous recombination: Implications for the radiation sensitivity of human lung cancer cell lines. British Journal of Cancer 92:1089-1097.
29. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. 2002. Quantitative detection of 125IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiation Research 158:486-492.
30. Takahashi A, Ohnishi T. 2005. Does gamma H2AX foci formation depend on the presence of DNA double strand breaks? Cancer Letters 229:171-179.
31. Yang HY, Anzenberg V, Held KD. 2007. The time dependence of, bystander responses induced by iron-ion radiation in normal human skin fibroblasts. Radiation Research 168:292-298.
32. Yasui LS, Chen K, Wang KT, Jones TP, Caldwell J, Guse D, Kassis AI. 2007. Using Hoechst 33342 to target radioactivity to the cell nucleus. Radiation Research 167:167-175.
33. Yu T, MacPhail SH, Banáth JP, Klokov D, Olive PL. 2006. Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. DNA Repair 5:935-946.